Works matching Tumor flare

Results: 87
    1
    2
    3
    4
    5

    Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.

    Published in:
    Arthritis & Rheumatology, 2018, v. 70, n. 9, p. 1508, doi. 10.1002/art.40509
    By:
    • Lovell, Daniel J.;
    • Johnson, Anne L.;
    • Huang, Bin;
    • Gottlieb, Beth S.;
    • Morris, Paula W.;
    • Kimura, Yukiko;
    • Onel, Karen;
    • Li, Suzanne C.;
    • Grom, Alexei A.;
    • Taylor, Janalee;
    • Brunner, Hermine I.;
    • Huggins, Jennifer L.;
    • Nocton, James J.;
    • Haines, Kathleen A.;
    • Edelheit, Barbara S.;
    • Shishov, Michael;
    • Jung, Lawrence K.;
    • Williams, Calvin B.;
    • Tesher, Melissa S.;
    • Costanzo, Denise M.
    Publication type:
    Article
    6
    7
    8

    The addition of CD20 monoclonal antibodies to lenalidomide improves response rates and survival in relapsed/refractory patients with chronic lymphocytic leukaemia relative to lenalidomide monotherapy - the MD Anderson Cancer Center experience.

    Published in:
    British Journal of Haematology, 2015, v. 171, n. 2, p. 281, doi. 10.1111/bjh.13377
    By:
    • Thompson, Philip A.;
    • Rozovski, Uri;
    • Keating, Michael J.;
    • Stingo, Francesco;
    • Smith, Susan C.;
    • Wierda, William G.;
    • Falchi, Lorenzo;
    • O'Brien, Susan M.;
    • Estrov, Zeev;
    • Burger, Jan A.;
    • Ferrajoli, Alessandra
    Publication type:
    Article
    9

    Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response.

    Published in:
    British Journal of Haematology, 2011, v. 155, n. 4, p. 457, doi. 10.1111/j.1365-2141.2011.08882.x
    By:
    • Chanan-Khan, Asher A.;
    • Chitta, Kasyapa;
    • Ersing, Noreen;
    • Paulus, Aneel;
    • Masood, Aisha;
    • Sher, Taimur;
    • Swaika, Abhisek;
    • Wallace, Paul K.;
    • Mashtare, Terry L.;
    • Wilding, Greg;
    • Lee, Kelvin;
    • Czuczman, Myron S.;
    • Borrello, Ivan;
    • Bangia, Naveen
    Publication type:
    Article
    10
    11
    12

    High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy.

    Published in:
    Arthritis & Rheumatology, 2018, v. 70, n. 4, p. 594, doi. 10.1002/art.40404
    By:
    • Mor‐Vaknin, Nirit;
    • Rivas, Miguel;
    • Legendre, Maureen;
    • Mohan, Smriti;
    • Yuanfan, Ye;
    • Mau, Theresa;
    • Johnson, Anne;
    • Huang, Bin;
    • Zhao, Lili;
    • Kimura, Yukiko;
    • Spalding, Steven J.;
    • Morris, Paula W.;
    • Gottlieb, Beth S.;
    • Onel, Karen;
    • Olson, Judyann C.;
    • Edelheit, Barbara S.;
    • Shishov, Michael;
    • Jung, Lawrence K.;
    • Cassidy, Elaine A.;
    • Prahalad, Sampath
    Publication type:
    Article
    13

    A12: The Role of Serum S100A12 Protein Levels in Disease Flare After Withdrawal of Anti-tumor Necrosis Factor Therapy in Polyarticular Forms of Juvenile Idiopathic Arthritis.

    Published in:
    Arthritis & Rheumatology, 2014, v. 66, p. S19, doi. 10.1002/art.38423
    By:
    • Hinze, Claas;
    • Foell, Dirk;
    • Johnson, Anne;
    • Kimura, Yukiko;
    • Spalding, Steven J.;
    • Morris, Paula W.;
    • Gottlieb, Beth;
    • Onel, Karen;
    • Olson, Judyann C.;
    • Edelheit, Barbara;
    • Shishov, Michael;
    • Jung, Lawrence;
    • Cassidy, Elaine;
    • Prahalad, Sampath;
    • Passo, Murray H.;
    • Beukelman, Timothy;
    • Mehta, Jay;
    • Schmidt, Kara M.;
    • Giannini, Edward H.;
    • Lovell, Daniel J.
    Publication type:
    Article
    14
    15
    16
    17
    18

    Occurrence and Prediction of Flare After Tapering of Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis.

    Published in:
    Journal of Rheumatology, 2024, v. 51, n. 1, p. 39, doi. 10.3899/jrheum.2023-0495
    By:
    • Wetterslev, Marie;
    • Georgiadis, Stylianos;
    • Christiansen, Sara Nysom;
    • Pedersen, Susanne Juhl;
    • Sørensen, Inge Juul;
    • Hetland, Merete Lund;
    • Duer, Anne;
    • Boesen, Mikael;
    • Gosvig, Kasper Kjærulf;
    • Møller, Jakob Møllenbach;
    • Bakkegaard, Mads;
    • Brahe, Cecilie Heegaard;
    • Krogh, Niels Steen;
    • Jensen, Bente;
    • Madsen, Ole Rintek;
    • Christensen, Jan;
    • Hansen, Annette;
    • Nørregaard, Jesper;
    • Røgind, Henrik;
    • Østergaard, Mikkel
    Publication type:
    Article
    19
    20
    21
    22

    Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL).

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 4, p. 327, doi. 10.1002/ajh.23946
    By:
    • Maddocks, Kami;
    • Wei, Lai;
    • Rozewski, Darlene;
    • Jiang, Yao;
    • Zhao, Yuan;
    • Adusumilli, Mikhil;
    • Pierceall, William E.;
    • Doykin, Camille;
    • Cardone, Michael H.;
    • Jones, Jeffrey A.;
    • Flynn, Joseph;
    • Andritsos, Leslie A.;
    • Grever, Michael R.;
    • Byrd, John C.;
    • Johnson, Amy J.;
    • Phelps, Mitch A.;
    • Blum, Kristie A
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.

    Published in:
    2018
    By:
    • Egle, Alexander;
    • Melchardt, Thomas;
    • Weiss, Lukas;
    • Pleyer, Lisa;
    • Greil, Richard;
    • Gassner, Franz Josef;
    • Zaborsky, Nadja;
    • Geisberger, Roland;
    • Catakovic, Kemal;
    • Hartmann, Tanja Nicole;
    • Steurer, Michael;
    • Voskova, Daniela;
    • Thaler, Josef;
    • Lang, Alois;
    • Girschikofsky, Michael;
    • Petzer, Andreas
    Publication type:
    journal article
    37
    38
    39
    40
    41
    42
    43

    Pre-Diagnosis Diet Predicts Response to Exclusive Enteral Nutrition and Correlates with Microbiome in Pediatric Crohn Disease.

    Published in:
    Nutrients, 2024, v. 16, n. 7, p. 1033, doi. 10.3390/nu16071033
    By:
    • Dijk, Stephanie;
    • Jarman, Megan;
    • Zhang, Zhengxiao;
    • Lawley, Morgan;
    • Ahmad, Muzammil;
    • Suarez, Ricardo;
    • Rossi, Laura;
    • Chen, Min;
    • Wu, Jessica;
    • Carroll, Matthew W.;
    • Otley, Anthony;
    • Sherlock, Mary;
    • Mack, David R.;
    • Jacobson, Kevan;
    • deBruyn, Jennifer C.;
    • El-Matary, Wael;
    • Deslandres, Colette;
    • Rashid, Mohsin;
    • Church, Peter C.;
    • Walters, Thomas D.
    Publication type:
    Article
    44
    45

    Lenalidomide and Chronic Lymphocytic Leukemia.

    Published in:
    BioMed Research International, 2013, v. 2013, p. 1, doi. 10.1155/2013/932010
    By:
    • González-Rodríguez, Ana Pilar;
    • Payer, Angel R.;
    • Acebes-Huerta, Andrea;
    • Huergo-Zapico, Leticia;
    • Villa-Alvarez, Monica;
    • Gonzalez-García, Esther;
    • Gonzalez, Segundo
    Publication type:
    Article
    46
    47
    48
    49
    50